---
figid: PMC12074914__fonc-15-1586137-g002
figtitle: MRPL13 regulates the PI3K/AKT/mTOR signaling pathway to promote proliferation,
  migration, and EMT in breast cancer cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12074914
filename: fonc-15-1586137-g002.jpg
figlink: /pmc/articles/PMC12074914/figure/F2/
number: F2
caption: MRPL13 regulates the PI3K/AKT/mTOR signaling pathway to promote proliferation,
  migration, and EMT in breast cancer cells. (1) Upregulation of the MRPL13 gene increases
  the synthesis of MRPL13 protein, (2) which in turn causes mitochondrial dysfunction.
  (3) This alteration in mitochondrial function aberrantly activates PI3K, (4) which
  phosphorylates PIP2 on the cell membrane to generate PIP3. (5) PIP3 recruits and
  activates AKT, (6) and phosphorylated AKT subsequently activates mTOR. Phosphorylated
  mTOR promotes proliferation and migration of breast cancer cells, as well as the
  EMT process. PI3K, Phosphoinositide 3-Kinase. PIP2, phosphatidylinositol-4,5-bisphosphate.
  PIP3, phosphatidylinositol-3,4,5-trisphosphate. AKT, Protein Kinase B. mTOR, Mechanistic
  Target of Rapamycin. EMT, epithelial-mesenchymal transition
papertitle: 'Mitochondrial ribosomal proteins: potential targets for cancer prognosis
  and therapy'
reftext: Jianqing Zhu, et al. Front Oncol. 2025;15(NA).
year: '2025'
doi: 10.3389/fonc.2025.1586137
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media SA
keywords: mitochondrial ribosomes proteins | cancer | tumor microenvironment | prognostic
  marker | therapeutic target
automl_pathway: 0.9382829
figid_alias: PMC12074914__F2
figtype: Figure
redirect_from: /figures/PMC12074914__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12074914__fonc-15-1586137-g002.html
  '@type': Dataset
  description: MRPL13 regulates the PI3K/AKT/mTOR signaling pathway to promote proliferation,
    migration, and EMT in breast cancer cells. (1) Upregulation of the MRPL13 gene
    increases the synthesis of MRPL13 protein, (2) which in turn causes mitochondrial
    dysfunction. (3) This alteration in mitochondrial function aberrantly activates
    PI3K, (4) which phosphorylates PIP2 on the cell membrane to generate PIP3. (5)
    PIP3 recruits and activates AKT, (6) and phosphorylated AKT subsequently activates
    mTOR. Phosphorylated mTOR promotes proliferation and migration of breast cancer
    cells, as well as the EMT process. PI3K, Phosphoinositide 3-Kinase. PIP2, phosphatidylinositol-4,5-bisphosphate.
    PIP3, phosphatidylinositol-3,4,5-trisphosphate. AKT, Protein Kinase B. mTOR, Mechanistic
    Target of Rapamycin. EMT, epithelial-mesenchymal transition
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - MRPL1
  - MRPL2
  - MRPL3
  - MRPL4
  - MRPL9
  - MRPL10
  - MRPL11
  - MRPL12
  - MRPL13
  - MRPL14
  - MRPL15
  - MRPL16
  - MRPL17
  - MRPL18
  - MRPL19
  - MRPL20
  - MRPL21
  - MRPL22
  - MRPL23
  - MRPL24
  - MRPL27
  - MRPL28
  - MRPL30
  - MRPL32
  - MRPL33
  - MRPL34
  - MRPL35
  - MRPL36
  - MRPL37
  - MRPL38
  - MRPL39
  - MRPL40
  - MRPL41
  - MRPL42
  - MRPL43
  - MRPL44
  - MRPL45
  - MRPL46
  - MRPL47
  - MRPL48
  - MRPL49
  - MRPL50
  - MRPL51
  - MRPL52
  - MRPL53
  - MRPL54
  - MRPL55
  - MRPL57
  - AKT1
  - AKT2
  - AKT3
  - ITK
  - SLC22A3
  - cancer
  - Breast cancer
  - breast cancer
---
